Aktie A12F27 CELL MEDX CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Cell MedX Corp.

Aktien

A12F27

US15115X1072

CMXC

Markt geschlossen - OTC Markets
Andere Börsenplätze
 17:45:34 03.05.2024 		% 5 Tage % 1. Jan.
0.03 USD +36.36% Intraday Chart für Cell MedX Corp. -6.25% +36.36%
15.04. Cell MedX Corp. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 29. Februar 2024 CI
28.02. Cell Medx Corp. gibt den Rücktritt von Brad Hargreaves aus dem Vorstand bekannt CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Cell MedX Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024
Cell MedX Corp. Closes Private Placement Financing
Cell MedX Corp. announced that it has received $0.075 million in funding
Cell MedX Corp. Announces Resignation of Director
Cell Medx Corp. Announces Resignation of Brad Hargreaves from the Board of Directors
Cell MedX Corp. Appoints Dr. George Adams as Chairman of the Board
Cell MedX Corp. Appoints George Adams as Chairman of the Board
Cell MedX Corp. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023
Cell MedX Corp. Announces New CEO and Directors and Debt Settlement
Cell MedX Corp. Announces Chief Executive Officer Changes
Cell MedX Corp. Announces Board Appointments
Cell MedX Corp. Announces Full Revocation of British Columbia Cease Trade Order
Cell MedX Corp. Announces Board Changes
Cell MedX Corp. Appoints Audit Committee and Accepts Resignation of Chief Operating Officer
Cell MedX Corp. Reports Earnings Results for the First Quarter Ended August 31, 2023
Cell MedX Corp. Reports Earnings Results for the Full Year Ended May 31, 2023
Cell MedX Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2023
Cell MedX Corp. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2022
CELL MEDX CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Cell MedX Corp. Reports Earnings Results for the First Quarter Ended August 31, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A12F27 Aktie
  4. Nachrichten Cell MedX Corp.
  5. Andere Sprachen